Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isophane insulin adverse reaction |
Causative agent (attribute) |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Porcine isophane insulin (substance) |
Is a |
True |
Isophane insulin |
Inferred relationship |
Some |
|
Isophane insulin nph |
Is a |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Allergy to isophane insulin |
Causative agent (attribute) |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Bovine isophane insulin (substance) |
Is a |
True |
Isophane insulin |
Inferred relationship |
Some |
|
Human isophane insulin (substance) |
Is a |
True |
Isophane insulin |
Inferred relationship |
Some |
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane human 100units/mL injection suspension 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Isophane insulin nph |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane porcine 100u/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 10/90 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 20/80 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 20/80 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 20/80 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 40/60 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 15/85 100u/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane human 25/75 100u/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane porcine 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane porcine 30/70 100u/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin biphasic isophane porcine 30/70 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing porcine isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing human isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing bovine isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing biphasic isophane insulin porcine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing biphasic isophane insulin human |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane human 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane human 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 10/90 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane human 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane bovine 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane bovine 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Allergy to isophane insulin |
Causative agent (attribute) |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Human isophane insulin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Bovine isophane insulin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Porcine isophane insulin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing isophane insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Isophane insulin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Isophane insulin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing only isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing only isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing only isophane insulin and recombinant human regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |
Product containing only isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |
Product containing isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing isophane insulin and recombinant human regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |
Product containing isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |